Drug information for DANTRIUM

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 100MG Prescription AB (Reference Drug) DANTROLENE SODIUM Dantrolene JHP PHARMS 17443
CAPSULE; ORAL 25MG Prescription AB  DANTROLENE SODIUM Dantrolene JHP PHARMS   "
CAPSULE; ORAL 50MG Prescription AB  DANTROLENE SODIUM Dantrolene JHP PHARMS   "
INJECTABLE; INJECTION 20MG/VIAL Prescription AP (Reference Drug) DANTROLENE SODIUM Dantrolene JHP PHARMS 18264
2008-11-07 Label

2008-10-27 Letter

Drug Adverse Effects information for DANTRIUM

Role code Indications Reaction # Reports
PS GAIT SPASTIC DIPLOPIA 3
PS GAIT SPASTIC EYE MOVEMENT DISORDER 3
PS SPINAL LIGAMENT OSSIFICATION ALTERED STATE OF CONSCIOUSNESS 1
PS SPINAL LIGAMENT OSSIFICATION CONDITION AGGRAVATED 1
PS SPINAL OSTEOARTHRITIS DIPLOPIA 2
PS SPINAL OSTEOARTHRITIS EYE MOVEMENT DISORDER 2
SS EPILEPSY APNOEA 1
SS EPILEPSY SOMNOLENCE 1
SS GAIT SPASTIC DIPLOPIA 3
SS GAIT SPASTIC EYE MOVEMENT DISORDER 3
SS NEUROLEPTIC MALIGNANT SYNDROME HEPATITIS FULMINANT 1
SS SPINAL OSTEOARTHRITIS DIPLOPIA 2
SS SPINAL OSTEOARTHRITIS EYE MOVEMENT DISORDER 2
C ANALGESIC THERAPY DIZZINESS 1
C ANALGESIC THERAPY DRUG EFFECT INCREASED 1
C ANALGESIC THERAPY DRUG INEFFECTIVE 1
C ANALGESIC THERAPY DRUG INTERACTION 1
C ANALGESIC THERAPY DYSARTHRIA 1
C ANALGESIC THERAPY NAUSEA 1
C ANALGESIC THERAPY SOMNOLENCE 1
C ANALGESIC THERAPY VOMITING 1
C BIPOLAR DISORDER BLOOD CREATINE PHOSPHOKINASE INCREASED 1
C BIPOLAR DISORDER CONFUSIONAL STATE 1
C BIPOLAR DISORDER DELIRIUM 1
C BIPOLAR DISORDER LETHARGY 1
C BIPOLAR DISORDER LUNG INFILTRATION 1
C BIPOLAR DISORDER MENTAL DISORDER 1
C BIPOLAR DISORDER MUSCULOSKELETAL STIFFNESS 1
C BIPOLAR DISORDER NEUROLEPTIC MALIGNANT SYNDROME 1
C BIPOLAR DISORDER PNEUMONIA 1
C BIPOLAR DISORDER VOMITING 1
C CEREBRAL PALSY BRONCHITIS 8
C CEREBRAL PALSY CYTOMEGALOVIRUS VIRAEMIA 8
C CEREBRAL PALSY DIARRHOEA 8
C CEREBRAL PALSY DYSKINESIA 8
C CEREBRAL PALSY EYE DISCHARGE 8
C CEREBRAL PALSY GASTROINTESTINAL HYPERMOTILITY 8
C CEREBRAL PALSY HYPERKALAEMIA 8
C CEREBRAL PALSY HYPERTENSION 8
C CEREBRAL PALSY HYPOTENSION 8
C CEREBRAL PALSY PNEUMONIA ASPIRATION 8
C CEREBRAL PALSY URINE OUTPUT DECREASED 8
C DIARRHOEA BRONCHITIS 8
C DIARRHOEA CYTOMEGALOVIRUS VIRAEMIA 8
C DIARRHOEA DIARRHOEA 8
C DIARRHOEA DYSKINESIA 8
C DIARRHOEA EYE DISCHARGE 8
C DIARRHOEA GASTROINTESTINAL HYPERMOTILITY 8
C DIARRHOEA HYPERKALAEMIA 8
C DIARRHOEA HYPERTENSION 8
C DIARRHOEA HYPOTENSION 8
C DIARRHOEA PNEUMONIA ASPIRATION 8
C DIARRHOEA URINE OUTPUT DECREASED 8
C DYSKINESIA BRONCHITIS 4
C DYSKINESIA CYTOMEGALOVIRUS VIRAEMIA 4
C DYSKINESIA DIARRHOEA 4
C DYSKINESIA DYSKINESIA 4
C DYSKINESIA EYE DISCHARGE 4
C DYSKINESIA GASTROINTESTINAL HYPERMOTILITY 4
C DYSKINESIA HYPERKALAEMIA 4
C DYSKINESIA HYPERTENSION 4
C DYSKINESIA HYPOTENSION 4
C DYSKINESIA PNEUMONIA ASPIRATION 4
C DYSKINESIA URINE OUTPUT DECREASED 4
C DYSURIA DIZZINESS 1
C DYSURIA DRUG EFFECT INCREASED 1
C DYSURIA DRUG INEFFECTIVE 1
C DYSURIA DRUG INTERACTION 1
C DYSURIA DYSARTHRIA 1
C DYSURIA NAUSEA 1
C DYSURIA SOMNOLENCE 1
C DYSURIA VOMITING 1
C EPILEPSY ANAEMIA 2
C EPILEPSY BLISTER 3
C EPILEPSY BRONCHITIS 4
C EPILEPSY C-REACTIVE PROTEIN INCREASED 3
C EPILEPSY CARDIO-RESPIRATORY ARREST 2
C EPILEPSY CELLULITIS 3
C EPILEPSY CYTOMEGALOVIRUS VIRAEMIA 4
C EPILEPSY DIARRHOEA 4
C EPILEPSY DYSKINESIA 4
C EPILEPSY EOSINOPHIL COUNT DECREASED 3
C EPILEPSY ERYTHEMA 3
C EPILEPSY EYE DISCHARGE 7
C EPILEPSY GASTROINTESTINAL HAEMORRHAGE 1
C EPILEPSY GASTROINTESTINAL HYPERMOTILITY 4
C EPILEPSY HYPERAEMIA 3
C EPILEPSY HYPERKALAEMIA 4
C EPILEPSY HYPERTENSION 4
C EPILEPSY HYPOTENSION 4
C EPILEPSY HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1
C EPILEPSY LYMPHOCYTE COUNT INCREASED 3
C EPILEPSY MONOCYTE COUNT INCREASED 3
C EPILEPSY NEUTROPHIL COUNT DECREASED 3
C EPILEPSY PNEUMONIA ASPIRATION 4
C EPILEPSY PYREXIA 3
C EPILEPSY RASH PUSTULAR 3
C EPILEPSY SKIN NECROSIS 3
C EPILEPSY STEVENS-JOHNSON SYNDROME 3
C EPILEPSY URINE OUTPUT DECREASED 4
C EPILEPSY WRONG TECHNIQUE IN DRUG USAGE PROCESS 2
C GASTROOESOPHAGEAL REFLUX DISEASE DIZZINESS 1
C GASTROOESOPHAGEAL REFLUX DISEASE DRUG EFFECT INCREASED 1
C GASTROOESOPHAGEAL REFLUX DISEASE DRUG INEFFECTIVE 1
C GASTROOESOPHAGEAL REFLUX DISEASE DRUG INTERACTION 1
C GASTROOESOPHAGEAL REFLUX DISEASE DYSARTHRIA 1
C GASTROOESOPHAGEAL REFLUX DISEASE NAUSEA 1
C GASTROOESOPHAGEAL REFLUX DISEASE SOMNOLENCE 1
C GASTROOESOPHAGEAL REFLUX DISEASE VOMITING 1
C HYPERKALAEMIA BRONCHITIS 4
C HYPERKALAEMIA CYTOMEGALOVIRUS VIRAEMIA 4
C HYPERKALAEMIA DIARRHOEA 4
C HYPERKALAEMIA DYSKINESIA 4
C HYPERKALAEMIA EYE DISCHARGE 4
C HYPERKALAEMIA GASTROINTESTINAL HYPERMOTILITY 4
C HYPERKALAEMIA HYPERKALAEMIA 4
C HYPERKALAEMIA HYPERTENSION 4
C HYPERKALAEMIA HYPOTENSION 4
C HYPERKALAEMIA PNEUMONIA ASPIRATION 4
C HYPERKALAEMIA URINE OUTPUT DECREASED 4
C HYPOTHYROIDISM BRONCHITIS 4
C HYPOTHYROIDISM CYTOMEGALOVIRUS VIRAEMIA 4
C HYPOTHYROIDISM DIARRHOEA 4
C HYPOTHYROIDISM DYSKINESIA 4
C HYPOTHYROIDISM EYE DISCHARGE 4
C HYPOTHYROIDISM GASTROINTESTINAL HYPERMOTILITY 4
C HYPOTHYROIDISM HYPERKALAEMIA 4
C HYPOTHYROIDISM HYPERTENSION 4
C HYPOTHYROIDISM HYPOTENSION 4
C HYPOTHYROIDISM PNEUMONIA ASPIRATION 4
C HYPOTHYROIDISM URINE OUTPUT DECREASED 4
C INFECTION ANAPHYLACTIC REACTION 1
C INFECTION PROPHYLAXIS BRONCHITIS 4
C INFECTION PROPHYLAXIS CYTOMEGALOVIRUS VIRAEMIA 4
C INFECTION PROPHYLAXIS DIARRHOEA 4
C INFECTION PROPHYLAXIS DYSKINESIA 4
C INFECTION PROPHYLAXIS EYE DISCHARGE 4
C INFECTION PROPHYLAXIS GASTROINTESTINAL HYPERMOTILITY 4
C INFECTION PROPHYLAXIS HYPERKALAEMIA 4
C INFECTION PROPHYLAXIS HYPERTENSION 4
C INFECTION PROPHYLAXIS HYPOTENSION 4
C INFECTION PROPHYLAXIS PNEUMONIA ASPIRATION 4
C INFECTION PROPHYLAXIS URINE OUTPUT DECREASED 4
C MINERAL SUPPLEMENTATION DIZZINESS 1
C MINERAL SUPPLEMENTATION DRUG EFFECT INCREASED 1
C MINERAL SUPPLEMENTATION DRUG INEFFECTIVE 1
C MINERAL SUPPLEMENTATION DRUG INTERACTION 1
C MINERAL SUPPLEMENTATION DYSARTHRIA 1
C MINERAL SUPPLEMENTATION NAUSEA 1
C MINERAL SUPPLEMENTATION SOMNOLENCE 1
C MINERAL SUPPLEMENTATION VOMITING 1
C MULTIPLE SCLEROSIS RELAPSE BLISTER 1
C MULTIPLE SCLEROSIS RELAPSE BURNING SENSATION 1
C MULTIPLE SCLEROSIS RELAPSE ERYTHEMA 1
C MULTIPLE SCLEROSIS RELAPSE PRURITUS 1
C MULTIPLE SCLEROSIS RELAPSE RASH 1
C MUSCLE SPASTICITY IMPLANT SITE EFFUSION 1
C MUSCLE SPASTICITY IMPLANT SITE HAEMATOMA 1
C MUSCLE SPASTICITY IMPLANT SITE OEDEMA 1
C MUSCLE SPASTICITY RESIDUAL URINE VOLUME INCREASED 1
C MUSCLE TIGHTNESS BLISTER 2
C MUSCLE TIGHTNESS C-REACTIVE PROTEIN INCREASED 2
C MUSCLE TIGHTNESS CELLULITIS 2
C MUSCLE TIGHTNESS EOSINOPHIL COUNT DECREASED 2
C MUSCLE TIGHTNESS ERYTHEMA 2
C MUSCLE TIGHTNESS EYE DISCHARGE 2
C MUSCLE TIGHTNESS HYPERAEMIA 2
C MUSCLE TIGHTNESS LYMPHOCYTE COUNT INCREASED 2
C MUSCLE TIGHTNESS MONOCYTE COUNT INCREASED 2
C MUSCLE TIGHTNESS NEUTROPHIL COUNT DECREASED 2
C MUSCLE TIGHTNESS PYREXIA 2
C MUSCLE TIGHTNESS RASH PUSTULAR 2
C MUSCLE TIGHTNESS SKIN NECROSIS 2
C MUSCLE TIGHTNESS STEVENS-JOHNSON SYNDROME 2
C PAIN DIZZINESS 6
C PAIN DRUG EFFECT INCREASED 6
C PAIN DRUG INEFFECTIVE 6
C PAIN DRUG INTERACTION 6
C PAIN DYSARTHRIA 6
C PAIN NAUSEA 6
C PAIN SOMNOLENCE 6
C PAIN VOMITING 6
C PAIN MANAGEMENT ARRHYTHMIA 1
C PROPHYLAXIS DIZZINESS 2
C PROPHYLAXIS DRUG EFFECT INCREASED 2
C PROPHYLAXIS DRUG INEFFECTIVE 2
C PROPHYLAXIS DRUG INTERACTION 2
C PROPHYLAXIS DYSARTHRIA 2
C PROPHYLAXIS NAUSEA 2
C PROPHYLAXIS SOMNOLENCE 2
C PROPHYLAXIS VOMITING 2
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER BRONCHITIS 8
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER CYTOMEGALOVIRUS VIRAEMIA 8
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER DIARRHOEA 8
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER DYSKINESIA 8
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER EYE DISCHARGE 8
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER GASTROINTESTINAL HYPERMOTILITY 8
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER HYPERKALAEMIA 8
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER HYPERTENSION 8
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER HYPOTENSION 8
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER PNEUMONIA ASPIRATION 8
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER URINE OUTPUT DECREASED 8
C RENAL TRANSPLANT BRONCHITIS 20
C RENAL TRANSPLANT CYTOMEGALOVIRUS VIRAEMIA 20
C RENAL TRANSPLANT DIARRHOEA 20
C RENAL TRANSPLANT DYSKINESIA 20
C RENAL TRANSPLANT EYE DISCHARGE 20
C RENAL TRANSPLANT GASTROINTESTINAL HYPERMOTILITY 20
C RENAL TRANSPLANT HYPERKALAEMIA 20
C RENAL TRANSPLANT HYPERTENSION 20
C RENAL TRANSPLANT HYPOTENSION 20
C RENAL TRANSPLANT PNEUMONIA ASPIRATION 20
C RENAL TRANSPLANT URINE OUTPUT DECREASED 20
C SCHIZOPHRENIA BLOOD CREATINE PHOSPHOKINASE INCREASED 1
C SCHIZOPHRENIA CONFUSIONAL STATE 1
C SCHIZOPHRENIA DELIRIUM 1
C SCHIZOPHRENIA LETHARGY 1
C SCHIZOPHRENIA LUNG INFILTRATION 1
C SCHIZOPHRENIA MENTAL DISORDER 1
C SCHIZOPHRENIA MUSCULOSKELETAL STIFFNESS 1
C SCHIZOPHRENIA NEUROLEPTIC MALIGNANT SYNDROME 1
C SCHIZOPHRENIA PNEUMONIA 1
C SCHIZOPHRENIA VOMITING 1
C SEDATIVE THERAPY BRONCHITIS 16
C SEDATIVE THERAPY CYTOMEGALOVIRUS VIRAEMIA 16
C SEDATIVE THERAPY DIARRHOEA 16
C SEDATIVE THERAPY DYSKINESIA 16
C SEDATIVE THERAPY EYE DISCHARGE 16
C SEDATIVE THERAPY GASTROINTESTINAL HYPERMOTILITY 16
C SEDATIVE THERAPY HYPERKALAEMIA 16
C SEDATIVE THERAPY HYPERTENSION 16
C SEDATIVE THERAPY HYPOTENSION 16
C SEDATIVE THERAPY PNEUMONIA ASPIRATION 16
C SEDATIVE THERAPY URINE OUTPUT DECREASED 16
C SEPSIS AGRANULOCYTOSIS 1
C SEPSIS MACULE 1
C THROMBOSIS PROPHYLAXIS BRONCHITIS 8
C THROMBOSIS PROPHYLAXIS CYTOMEGALOVIRUS VIRAEMIA 8
C THROMBOSIS PROPHYLAXIS DIARRHOEA 8
C THROMBOSIS PROPHYLAXIS DYSKINESIA 8
C THROMBOSIS PROPHYLAXIS EYE DISCHARGE 8
C THROMBOSIS PROPHYLAXIS GASTROINTESTINAL HYPERMOTILITY 8
C THROMBOSIS PROPHYLAXIS HYPERKALAEMIA 8
C THROMBOSIS PROPHYLAXIS HYPERTENSION 8
C THROMBOSIS PROPHYLAXIS HYPOTENSION 8
C THROMBOSIS PROPHYLAXIS PNEUMONIA ASPIRATION 8
C THROMBOSIS PROPHYLAXIS URINE OUTPUT DECREASED 8
C VITAMIN SUPPLEMENTATION DIZZINESS 1
C VITAMIN SUPPLEMENTATION DRUG EFFECT INCREASED 1
C VITAMIN SUPPLEMENTATION DRUG INEFFECTIVE 1
C VITAMIN SUPPLEMENTATION DRUG INTERACTION 1
C VITAMIN SUPPLEMENTATION DYSARTHRIA 1
C VITAMIN SUPPLEMENTATION NAUSEA 1
C VITAMIN SUPPLEMENTATION SOMNOLENCE 1
C VITAMIN SUPPLEMENTATION VOMITING 1
Ads by Google